66 related articles for article (PubMed ID: 25620178)
1. The mechanism and significance of E-cadherin, anti-apoptosis B-cell lymphoma-2 protein and sE-cadherin roles in cancer.
Liu L; Li HX; Lv XQ
J Biol Regul Homeost Agents; 2014; 28(4):683-91. PubMed ID: 25620178
[TBL] [Abstract][Full Text] [Related]
2. Beyond a tumor suppressor: Soluble E-cadherin promotes the progression of cancer.
Hu QP; Kuang JY; Yang QK; Bian XW; Yu SC
Int J Cancer; 2016 Jun; 138(12):2804-12. PubMed ID: 26704932
[TBL] [Abstract][Full Text] [Related]
3. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis.
Oka H; Shiozaki H; Kobayashi K; Inoue M; Tahara H; Kobayashi T; Takatsuka Y; Matsuyoshi N; Hirano S; Takeichi M
Cancer Res; 1993 Apr; 53(7):1696-701. PubMed ID: 8453644
[TBL] [Abstract][Full Text] [Related]
4. Double strand RNA-guided endogeneous E-cadherin up-regulation induces the apoptosis and inhibits proliferation of breast carcinoma cells in vitro and in vivo.
Junxia W; Ping G; Yuan H; Lijun Z; Jihong R; Fang L; Min L; Xi W; Ting H; Ke D; Huizhong Z
Cancer Sci; 2010 Aug; 101(8):1790-6. PubMed ID: 20518789
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin decreased human breast cancer cells sensitivity to staurosporine by up-regulating Bcl-2 expression.
Wang L; Li Z; Wang C; Yang Y; Sun L; Yao W; Cai X; Wu G; Zhou F; Zha X
Arch Biochem Biophys; 2009 Jan; 481(1):116-22. PubMed ID: 18983973
[TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin reduces bcl-2 expression and increases sensitivity to etoposide-induced apoptosis.
Sasaki CY; Lin Hc; Passaniti A
Int J Cancer; 2000 Jun; 86(5):660-6. PubMed ID: 10797287
[TBL] [Abstract][Full Text] [Related]
7. Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells.
Vizirianakis IS; Chen YQ; Kantak SS; Tsiftsoglou AS; Kramer RH
Int J Oncol; 2002 Jul; 21(1):135-44. PubMed ID: 12063560
[TBL] [Abstract][Full Text] [Related]
8. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
9. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements.
Hajra KM; Ji X; Fearon ER
Oncogene; 1999 Dec; 18(51):7274-9. PubMed ID: 10602481
[TBL] [Abstract][Full Text] [Related]
10. Relationship of p53, Bcl-2, Ki-67 index and E-cadherin expression in early invasive breast cancers with comedonecrosis as an accelerated apoptosis.
Hosaka N; Ryu T; Cui W; Li Q; Nishida A; Miyake T; Takaki T; Inaba M; Ikehara S
J Clin Pathol; 2006 Jul; 59(7):692-8. PubMed ID: 16473926
[TBL] [Abstract][Full Text] [Related]
11. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins.
Pan W; Ishii H; Ebihara Y; Gobe G
J Surg Oncol; 2003 Feb; 82(2):104-10. PubMed ID: 12561066
[TBL] [Abstract][Full Text] [Related]
12. RY10-4 suppressed metastasis of MDA-MB-231 by stabilizing ECM and E-cadherin.
Liu Z; Liu Z; Zhang X; Xue P; Zhang H
Biomed Pharmacother; 2014 May; 68(4):439-45. PubMed ID: 24721328
[TBL] [Abstract][Full Text] [Related]
13. Cadherin engagement protects human β-cells from apoptosis.
Parnaud G; Gonelle-Gispert C; Morel P; Giovannoni L; Muller YD; Meier R; Borot S; Berney T; Bosco D
Endocrinology; 2011 Dec; 152(12):4601-9. PubMed ID: 21990317
[TBL] [Abstract][Full Text] [Related]
14. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
[TBL] [Abstract][Full Text] [Related]
15. P-cadherin role in normal breast development and cancer.
Albergaria A; Ribeiro AS; Vieira AF; Sousa B; Nobre AR; Seruca R; Schmitt F; Paredes J
Int J Dev Biol; 2011; 55(7-9):811-22. PubMed ID: 22161837
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2.
Ferreira AC; Suriano G; Mendes N; Gomes B; Wen X; Carneiro F; Seruca R; Machado JC
Hum Mol Genet; 2012 Jan; 21(2):334-43. PubMed ID: 21989054
[TBL] [Abstract][Full Text] [Related]
17. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
19. Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer.
Mareel M; Vleminckx K; Vermeulen S; Yan G; Bracke M; van Roy F
Princess Takamatsu Symp; 1994; 24():63-80. PubMed ID: 8983064
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells.
van Horssen R; Hollestelle A; Rens JA; Eggermont AM; Schutte M; Ten Hagen TL
Breast Cancer Res Treat; 2012 Nov; 136(2):365-77. PubMed ID: 23053649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
